501 related articles for article (PubMed ID: 18355849)
21. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
[TBL] [Abstract][Full Text] [Related]
22. Prospective study of polydimethylsiloxane vs dextranomer/hyaluronic acid injection for treatment of vesicoureteral reflux.
Moore K; Bolduc S
J Urol; 2014 Dec; 192(6):1794-9. PubMed ID: 24928269
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.
Stenberg A; Larsson E; Läckgren G
J Urol; 2003 Mar; 169(3):1109-13. PubMed ID: 12576864
[TBL] [Abstract][Full Text] [Related]
24. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
Yu RN; Roth DR
Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
[TBL] [Abstract][Full Text] [Related]
25. The role of intraoperative cystography following the injection of dextranomer/hyaluronic acid copolymer.
Palmer LS
J Urol; 2008 Mar; 179(3):1118-20; discussion 1121. PubMed ID: 18206944
[TBL] [Abstract][Full Text] [Related]
26. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid.
Puri P; Mohanan N; Menezes M; Colhoun E
J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016
[TBL] [Abstract][Full Text] [Related]
27. Subureteral injection of dextranomer/hyaluronic acid copolymer for persistent vesicoureteral reflux following ureteroneocystostomy.
Jung C; DeMarco RT; Lowrance WT; Pope JC; Adams MC; Dietrich MS; Brock JW
J Urol; 2007 Jan; 177(1):312-5. PubMed ID: 17162075
[TBL] [Abstract][Full Text] [Related]
28. Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup.
Lee EK; Gatti JM; Demarco RT; Murphy JP
J Urol; 2009 Apr; 181(4):1869-74; discussion 1874-5. PubMed ID: 19233403
[TBL] [Abstract][Full Text] [Related]
29. Histology proved malpositioning of dextranomer/hyaluronic acid in submucosal ureter in patients after failed endoscopic treatment of vesicoureteral reflux.
Ben-Meir D; Morgenstern S; Sivan B; Efrat R; Livne PM
J Urol; 2012 Jul; 188(1):258-61. PubMed ID: 22595062
[TBL] [Abstract][Full Text] [Related]
30. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection.
Routh JC; Reinberg Y; Ashley RA; Inman BA; Wolpert JJ; Vandersteen DR; Husmann DA; Kramer SA
J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019
[TBL] [Abstract][Full Text] [Related]
31. Postoperative ureteral obstruction after subureteral injection of dextranomer/hyaluronic Acid copolymer.
Vandersteen DR; Routh JC; Kirsch AJ; Scherz HC; Ritchey ML; Shapiro E; Wolpert JJ; Pfefferle H; Reinberg Y
J Urol; 2006 Oct; 176(4 Pt 1):1593-5. PubMed ID: 16952696
[TBL] [Abstract][Full Text] [Related]
32. Can we rely on the presence of dextranomer-hyaluronic acid copolymer mounds on ultrasound to predict vesicoureteral reflux resolution after injection therapy?
Zamilpa I; Koyle MA; Grady RW; Joyner BD; Shnorhavorian M; Lendvay TS
J Urol; 2011 Jun; 185(6 Suppl):2536-41. PubMed ID: 21555031
[TBL] [Abstract][Full Text] [Related]
33. Long-term followup after endoscopic treatment of vesicoureteral reflux with dextranomer/hyaluronic acid copolymer in patients with neurogenic bladder.
Polackwich AS; Skoog SJ; Austin JC
J Urol; 2012 Oct; 188(4 Suppl):1511-5. PubMed ID: 22910250
[TBL] [Abstract][Full Text] [Related]
34. Postoperative cystography and endoscopic treatment of low-grade vesicoureteral reflux.
Harper L; Boutchkova S; Lavrand F; Vergnes P; Semjen F; Dobremez E
J Laparoendosc Adv Surg Tech A; 2008 Jun; 18(3):461-3. PubMed ID: 18503385
[TBL] [Abstract][Full Text] [Related]
35. Early discontinuation of antibiotic prophylaxis in patients with persistent primary vesicoureteral reflux initially detected during infancy: outcome analysis and risk factors for febrile urinary tract infection.
Moriya K; Mitsui T; Kitta T; Nakamura M; Kanno Y; Kon M; Nishimura Y; Shinohara N; Nonomura K
J Urol; 2015 Feb; 193(2):637-42. PubMed ID: 25111912
[TBL] [Abstract][Full Text] [Related]
36. Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.
Chertin B; Natsheh A; Fridmans A; Shenfeld OZ; Farkas A
J Urol; 2009 Oct; 182(4 Suppl):1703-6. PubMed ID: 19692032
[TBL] [Abstract][Full Text] [Related]
37. Salvage dextranomer-hyaluronic acid copolymer for persistent reflux after ureteral reimplantation: early success rates.
Bar-Yosef Y; Castellan M; Joshi D; Labbie A; Gosalbez R
J Urol; 2011 Jun; 185(6 Suppl):2531-4. PubMed ID: 21555029
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic treatment of vesicoureteral reflux associated with paraureteral diverticula in children.
Cerwinka WH; Scherz HC; Kirsch AJ
J Urol; 2007 Oct; 178(4 Pt 1):1469-73. PubMed ID: 17706704
[TBL] [Abstract][Full Text] [Related]
39. Endoscopic treatment for high grade vesicoureteral reflux in infants.
Dawrant MJ; Mohanan N; Puri P
J Urol; 2006 Oct; 176(4 Pt 2):1847-50. PubMed ID: 16945670
[TBL] [Abstract][Full Text] [Related]
40. Long-term incidence of febrile UTI after DxHA treatment of VUR.
Fotso Kamdem A; Galli G; Aubert D
J Pediatr Urol; 2014 Feb; 10(1):56-61. PubMed ID: 23810062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
